JotPsych Adds E-Prescribing to Mental Health Platform
JotPsych, a clinical platform for behavioral health, has launched JotRx, an integrated e-prescribing system. The new feature allows clinicians to move from session recording and note completion to issuing a prescription within a single patient record. This makes JotPsych a more comprehensive clinical operations platform for mental health providers.
- JotPsych was founded in 2023 by CEO Nathan Peereboom, who grew up in a medical family, and CTO Jackson Bierfeldt, whose background is in psycholinguistics and natural language processing. They were long-time friends from the University of Chicago before starting the company. - The company's initial product is an AI-powered scribe that reduces documentation time for behavioral health providers by over 90%. Before adding e-prescribing, the platform already automated lab orders, intake forms, and patient communication. - In July 2025, JotPsych announced a $5 million seed funding round led by Base10 Partners, a San Francisco-based VC firm with investments in companies like Figma and Stripe. This brought the company's total funding to between $5 million and $5.5 million. - The new funding is intended to accelerate the company's transition from an AI scribe to the first "fully agentic Electronic Health Record (EHR)," a system that doesn't just document care but actively helps orchestrate it. - The company is using the investment to hire more engineering talent and build out features like automated coding, billing, and intelligent scheduling. - While bootstrapped, the company became revenue-generating within six months of its founding in 2023. In 2024, JotPsych reported growth of over 1300% and had processed more than 1,000,000 patient encounters. - Although its founders have ties to Cleveland and the company has a Washington, D.C. headquarters, it serves clinicians across the US, Canada, Europe, Australia, and New Zealand.
